(Reuters) - Pfizer, which ousted Chief Executive Hank McKinnell last July after a disappointing pipeline of new medicines sent its share price to multi-year lows, said Levin had resigned to pursue career opportunities outside of Pfizer.
John LaMattina, president of global research and development, will also leave his post and retire by the end of this year after 30 years with the company.
Read more at Reuters.com Business News
John LaMattina, president of global research and development, will also leave his post and retire by the end of this year after 30 years with the company.
Read more at Reuters.com Business News
No comments:
Post a Comment